217 related articles for article (PubMed ID: 29714651)
1. Hypereosinophilic syndrome preceding a diagnosis of B-cell lymphoma.
Samarghandi A; Ahuja S; Jindal V; Gupta S; Fulger I
Tumori; 2018 Dec; 104(6):NP22-NP24. PubMed ID: 29714651
[TBL] [Abstract][Full Text] [Related]
2. Modern diagnosis and treatment of primary eosinophilia.
Tefferi A
Acta Haematol; 2005; 114(1):52-60. PubMed ID: 15995325
[TBL] [Abstract][Full Text] [Related]
3. Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.
Khoury P; Desmond R; Pabon A; Holland-Thomas N; Ware JM; Arthur DC; Kurlander R; Fay MP; Maric I; Klion AD
Allergy; 2016 Jun; 71(6):803-10. PubMed ID: 26797802
[TBL] [Abstract][Full Text] [Related]
4. The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease.
Yamada Y; Rothenberg ME; Lee AW; Akei HS; Brandt EB; Williams DA; Cancelas JA
Blood; 2006 May; 107(10):4071-9. PubMed ID: 16418325
[TBL] [Abstract][Full Text] [Related]
5. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
6. Early-Stage Loeffler's Endocarditis with Isolated Right Ventricular Involvement: Management, Long-Term Follow-Up, and Review of Literature.
Beedupalli J; Modi K
Echocardiography; 2016 Sep; 33(9):1422-7. PubMed ID: 27172873
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia.
Curtis C; Ogbogu PU
Immunol Allergy Clin North Am; 2015 Aug; 35(3):387-402. PubMed ID: 26209891
[TBL] [Abstract][Full Text] [Related]
8. Primary eosinophilic disorders: a concise review.
Pardanani A; Tefferi A
Curr Hematol Malig Rep; 2008 Jan; 3(1):37-43. PubMed ID: 20425445
[TBL] [Abstract][Full Text] [Related]
9. A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase: case report.
Rodzaj M; Gałazka K; Majewski M; Zduńczyk A
Pol Arch Med Wewn; 2009 Dec; 119(12):838-41. PubMed ID: 20010473
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms.
Osowo A; Fetten J; Navaneethan S
South Med J; 2006 Feb; 99(2):188-9. PubMed ID: 16509562
[TBL] [Abstract][Full Text] [Related]
11. [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
Isvy-Joubert A; Hickman G; Flageul B; Battistella M; Bagot M; Galicier L; Petit A
Ann Dermatol Venereol; 2012 Oct; 139(10):636-40. PubMed ID: 23122377
[TBL] [Abstract][Full Text] [Related]
12. [The Lymphoid Variant of HES (L-HES) as Differential Diagnose of Severe Asthma in Childhood].
Leu T; Rauthe S; Wirth C; Simon HU; Kunzmann V; Hebestreit H; Kunzmann S
Klin Padiatr; 2016 Nov; 228(6-07):319-324. PubMed ID: 27846662
[TBL] [Abstract][Full Text] [Related]
13. Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
Voeller J; DeNapoli T; Griffin TC
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1710. PubMed ID: 36241191
[TBL] [Abstract][Full Text] [Related]
14. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract][Full Text] [Related]
15. Response to imatinib mesylate in patients with hypereosinophilic syndrome.
Arefi M; García JL; Briz MM; de Arriba F; Rodríguez JN; Martín-Núñez G; Martínez J; López J; Suárez JG; Moreno MJ; Merino MA; Gutiérrez NC; Hernández-Rivas JM
Int J Hematol; 2012 Sep; 96(3):320-6. PubMed ID: 22806436
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma.
Rapanotti MC; Caruso R; Bernardini S; Coletti V; Lo-Coco F; De Rossi G
Leuk Res; 2005 Aug; 29(8):975-9. PubMed ID: 15978951
[TBL] [Abstract][Full Text] [Related]
17. Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome.
Merlotto MR; Cantadori LO; Sakabe D; Miot HA
An Bras Dermatol; 2018 Jun; 93(3):451-453. PubMed ID: 29924226
[TBL] [Abstract][Full Text] [Related]
18. Ascites in a young male: idiopathic FIP1L1-PDGFRA-negative hypereosinophilic syndrome.
Kasinathan G; Sathar J
JRSM Open; 2020 Jan; 11(1):2054270419894826. PubMed ID: 32002188
[TBL] [Abstract][Full Text] [Related]
19. Hypereosinophilic Syndrome, Multiorgan Involvement and Response to Imatinib.
Hana CK; Caldera H
Cureus; 2020 Jun; 12(6):e8493. PubMed ID: 32656011
[TBL] [Abstract][Full Text] [Related]
20. [Eosinophilic ascites as a presenting symptom of the hypereosinophilic syndrome].
Rimbrot S; Bennett M; Komorovski M; Levy Y
Harefuah; 2001 Jun; 140(6):471-2, 567. PubMed ID: 11420842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
